6 minute read
ABRONN: EMBRACING TECHNOLOGY TO ENABLE
Medical facilities on the go
WITH THE DEVELOPMENT OF INFORMATION TECHNOLOGY, THE CONCEPT OF SMART HEALTHCARE HAS GRADUALLY COME TO THE FORE VISION, ITS RELATIONSHIP WITH JAFZA, THE EFFECTS OF COVID-19, AND PLANS FOR THE FUTURE.
Advertisement
Mohamed Ahmed Al Mubarak, Chairman of Abronn shares insights on the growth of the company that was established in 2017 in Jafza with the primary aim of providing mobile healthcare solutions and medical equipment for hospitals and medical facilities.
How has Abronn’s market position changed over time as a leading supplier of innovative healthcare solutions, medical units and special vehicles? We started as a medical equipment trading company with a focus on emergency equipment. Post that, the company evolved and we started manufacturing mobile healthcare solutions like ambulances, emergency vehicles, medical units, rescue units and eventually mobile clinics and hospitals. Today, we also do all hospital equipment and field hospitals.
Considering the current worldwide healthcare crisis, how has it highlighted the significance of efficient distribution and supply of healthcare solutions? In this crisis, the world has realized the importance of emergency medical solutions in general and especially for mobile healthcare solutions. You must have access to a field hospital, a mobile hospital with fast implementation, which means within a few weeks you should be done with a complete field hospital to ensure that the patients will get good service and have access to distinctive healthcare solutions.
What strategies and technological advancements has Abronn adopted to overcome the market challenges? Our team of experts has embraced several technologies to speed up production. Additionally, we are also utilising the power of digital media to spread awareness about our mobile healthcare solutions in the region and all over the world.
How do you ensure quality products to your customers? We have received our ISO Certification 9001, ISO certificate 13485, which are related to manufacturing of medical items. We also have the ISO 14001 and 45001. Additionally, we are the only company in the region that currently has the “CE” certificate for products like mobile units, ambulances and emergency equipment.
Currently there is an uptick in the need for medical and emergency equipment. How did you meet the
increasing demand for medical equipment, ambulances and field hospitals? We have established close ties with several suppliers. Also, we are a distributor for many brands of well-reputed factories all over the world. Our stock is manufactured in our facility here. As you know, Dubai is considered as a hub for the Middle East and many places, so we are ensuring that we are prepared for any crisis that may happen by keeping our logistics ready, so it can be immediately dispatched once there is demand.
How did your facility in Jafza help to meet the rising demand? Currently, we have a 25,00 square meter facility in Jafza, which is the main free zone in the region and has the main port. As we operate in a very challenging sector such as Healthcare, I do see the significant added value of Jafza’s incentives such as tax-free, import and export which are facilitating our work operations.
What technologies have been installed in your Jafza facility to enhance production? We have used all modern technologies such as the fiberglass “GRB’’ that is used in ambulances. We are also utilizing the ABS molds and CNC machines to do all the interiors and the parts of our products accurately with proper finishing. We do manufacture all our metalwork in-house including steel, aluminium and fabrication of the boxes and accessories or the installation. Such technologies are maximizing our work efficiency and effectiveness.
How has being a part of Jafza added value to Abronn’s healthcare and pharmaceutical segment? In Jafza, we feel secure and supported with all the facilities they offer, including flexible administration work, easy import and export. There are many logistics companies that are also supporting us for storage and shipping purposes all over the world. Moreover, since Dubai is a hub for the Middle East, Africa and Asia mainly, being in Jafza has helped us a lot to supply these regions efficiently with all high-quality products.
How does COVID-19 transform the efficient delivery of medical supplies?
WITH COVID-19 CASES RISING ON A DAILY BASIS, PHARMACEUTICAL COMPANIES LEVELLED UP THE PRODUCTION OF THEIR MEDICAL SUPPLIES IN ORDER TO MEET THE DEMANDS OF THE PEOPLE
Since the outbreak of the pandemic, the availability and delivery of large quantities of medical products have been an essential need. Although the production of supplies increased significantly to help curb the critical situation, what remained a challenge was the distribution of these supplies to the right customers in a time-efficient manner. Despite the fact that a crisis was being dealt with, the positive part was that the supply chain sector advanced itself with the adoption of solutions that would increase the efficiency of the delivery process.
The latest supply chain solutions that were adopted ensured full visibility, safety, and tamper-proof distribution of the medical products, despite the complexities of their transportation. These solutions were adopted by leading manufacturers and distributors of pharmaceutical products such as Biotech Pharma Services and were used to benefit millions of people around the globe.
Cloud-based networks for efficient distribution Biotech Pharma is one of the leading distributors of premium pharmaceutical products in the Middle East and has over a decade of experience in the medical industry. It is specialized in patent licensing, product creation, regulatory relations, distribution, product launch, contracting, and commercialization.
Huthaifa Salem, General Manager, Biotech Pharma Services emphasised, “As the pandemic continued and increased the need for efficient delivery of pharmaceutical supplies, Biotech Pharma adopted cloud-based networks as part of its supply chain systems in order to maintain up-to-date and end-to-end supply chain visibility to deliver the desired product to the consumer within 24 to 48 hours. That’s why, we have managed to achieve a sales growth of 48 per cent.”
Cost-effectivve marketing solutions Biotech Pharma goes far beyond dealing with only pharmaceutical products and facilities, and also focuses on the development and execution of detailed sales and marketing plans for each brand it works with. Moreover, it also takes care of marketing authorization applications for human health, herbal, and pharmaceutical products, as well as regulatory aspects of production sites and marketing authorization holders, through its multidisciplinary team of regulatory affairs experts. The company’s regulatory affairs team helps its clients in determining the quickest and most cost-effective path to market their products, and also provides resources for the life cycle management of these products. Salem clarified, “When it comes to creating a customized regulatory strategy for pharmaceutical products, we are a onestop-shop for our clients, guiding them through the licensing process by helping them get through hurdles and authority interactions.” Once the registration process is completed, Biotech Pharma’s Regulatory Affairs team assists its customers in the life cycle management of variations, line additions, renewals, PSUR applications, and responses to authority demands for their products, all while maintaining compliance with regulatory standards.
He concluded, “We will pursue our commitment to the provision of the highest quality of Health and Medical Services for our customers in the GCC as we aim to maintain our outstanding quality of support and services for our principal companies. Our key concern and support are given to our staff, who are our true backbone in reinforcing our success.”
HUTHAIFA SALEM, GENERAL MANAGER, BIOTECH PHARMA SERVICES
